Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4385_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
81 Мб
Скачать
AETIOLOGY OF HEAD AND NECK CANCER
countries. When marijuana is smoked, a wide range of potential carcinogens are released and absorbed, with an overall risk of 2.6 compared to non-users.
Alcohol
Alcohol is believed to act in a synergistic fashion with tobacco; however, some case control and cohort studies have shown an increased risk of cancer even in non-smokers. Alcohol itself is not a carcinogen, so possible carcinogenic mechanisms include alcohol acting as a solvent, non-alcohol constituents of alcoholic drinks, the alcohol metabolite acetaldehyde, activation of the cytochrome p450 system, decreased activity of DNA repair enzymes or T cells or the associated nutritional deciencies associated with heavy alcohol intake.
Dental Factors
Poor oral hygiene is associated with oral cancer. is may be due to chronic inammation of the gingiva or an alteration in the oral microbiome. ere is some evidence suggesting mouthwashes containing alcohol may also be important.
Infections
In oral cancer, several viruses have been implicated in carcinogenesis including HPV, human immunodeciency virus (HIV) and herpes simplex virus (HSV).
Human Papillomavirus
Some authors have dismissed a link between oral cavity cancer and HPV infection due to low prevalence. In contrast, other authors have reported that the infection of oral cavity cells by HPV is not rare, and the relationship is not resolved.
Human Immunodeciency Virus
A study from New York showed HIV infection in 5% of head and neck cancer patients. Due to the depressed immunity in HIV patients, the head and neck cancers observed were more advanced in the HIV group.
Herpes Simplex Virus
Several studies have shown that patients with oral cancer have higher antibodies to HSV. However, there is little evidence that HSV gene sequences are present in oral cancer cells or any evidence of gene integration.
Nutritional Factors
Several studies suggest high fruit and vegetable intake is associated with a decreased risk of head and neck cancer. is may be due to increased intake of the antioxidants or free radical scavenging vitamins A, C and E.
Genetic and Immunologic Predisposition
Although smoking is the main risk factor, not all people who smoke develop head and neck cancer. ere are several genetic conditions that are associated with increased risk of head and neck cancer including Li-Fraumeni syndrome (p53 gene mutation), Fanconi’s anaemia, Bloom syndrome and ataxia-telangiectasia.
Patients treated with bone marrow transplants and organ transplants have an increased inci­dence of skin cancer and oral cavity cancer, possibly due to the long-term use of immunosup­pressive drugs.
Cancer of the Oropharynx
Recent studies have shown a dramatic change in the aetiology of oropharyngeal cancer from a cancer caused by smoking and alcohol to a cancer now predominantly caused by HPV. e increase in tonsil and base of tongue cancer over the last decade is largely due to HPV infec­tion of the palatine and lingual tonsils, and it has been called an epidemic of HPV-associated oropharyngeal cancer.
258 Head and Neck
AETIOLOGY OF HEAD AND NECK CANCER
HPV exists in many dierent serotypes and HPV 16, 18, 31, 33, 35 and 39 are associated with head and neck c ancer and HPV 16 and 18 are the most com mon types as sociated with squ amous cell carcinoma. e E6 and E7 open reading frames (ORFs) of the high-risk HPVs are impor­tant. ey bind to and inactivate tumour suppressor genes p53 and pRb, respectively, allowing uncontrolled cell proliferation, resulting in genomic instability and cellular transformation.
Patients with HPV-positive tonsil cancer tend to be young, non-smokers and non-drinkers. e molecular characteristics are completely dierent from HPV-negative tonsil cancers. HPV-positive tonsil cancers have shown a better prognosis.
Cancer of the Larynx and Hypopharynx
e numbers of new cases of laryngeal cancer are falling by around 2% to 3% a year, mainly because fewer people are smoking.
Tobacco and Alcohol
ere is a strong association between laryngeal c ancer and cigarette smoking. Environmental tobacco smoke also increases the risk of laryngeal cancer. e combined use of tobacco and alcohol increases the risk of laryngeal cancer by 50% over the estimated risk if these fac­tors were considered additive. e risk is greater for hypopharyngeal cancer than laryngeal cancer.
Other Factors
Laryngeal cancer is also associated with nickel and mustard gas exposure and there may be association with asbestos exposure. Postcricoid carcinoma is associated with previous radia­tion and sideropenic dysphagia - between 4% and 6% of patients have a history of Plummer­Vinson syndrome.
Cancer of the Nasopharynx
Nasopharyngeal cancer (NPC) is endemic in southern China and Hong Kong with an inci­dence rate of 50 per 100 000.
ere are three subtypes: World Health Organisation (WHO) type 1, keratinising squamous cell carcinoma; WHO type 2, non-keratinising (dierentiated) carcinoma and WHO type 3, undierentiated carcinoma. In North America, type 1 accounts for 68% of cases whereas in the Far East, types 2 and 3 account for 95% of cases. ere is a genetic association, with dier­ent types of HLA types, and a familial association. e most important environmental factor is infection by Epstein-Barr virus (EBV).
Dietary factors are also important. People who live in aected areas where NPC is common typically eat diets very high in salt-cured sh and meat. Studies indicate that foods preserved in this way that are cooked at high temperatures may produce chemicals that can damage DNA.
Cancer of the Nasal Cavity and Paranasal Sinuses
Cancers of the nasal cavity and paranasal sinuses are rare. As in all head and neck cancer, smoking tobacco is a risk factor for nasal cavity cancer. Occupational factors are also impor­tant including exposure to dust from wood, textiles and leather and possibly our.
Non-Squamous Malignant Tumours
Carcinoma of the Thyroid
Dierentiated thyroid cancer (DTC) accounts for 80% of thyroid cancers, split into papil­lary and follicular cancer. Other thyroid tumours include poorly dierentiated cancer (10%), anaplastic (5%) and medullary thyroid cancer (MTC; 5%). e incidence of papillary thyroid cancer is increasing, which is partly the result of the incidental detection of early thyroid cancer because of increasing use of imaging.
yroid cancer is more common in areas of the world where diets are low in iodine, but there is not a strong epidemiological relationship between iodine intake and cancer. A history of radiation treatment in childhood is a known risk factor. Inherited medical conditions such
Head and Neck 259
AETIOLOGY OF HEAD AND NECK CANCER
as Gardner syndrome, familial polyposis and Cowden disease have an increased incidence of thyroid cancer. Certain families also have an increased incidence of papillary thyroid cancer.
MTC originates from the parafollicular C cells, secretes calcitonin and occurs in both spo­radic and hereditary forms. Seventy-ve percent of MTC occurs as a sporadic form and 25% as a hereditary form. e hereditary forms can occur in the hereditary syndrome multiple endocrine neoplasia syndrome type A (MEN-2A), in MEN-2B or as a single component in a hereditary disease (familial MTC). Both MEN-2 syndromes are autosomal dominant genetic disorders characterised by mutations in the RET proto-oncogene.
Salivary Gland Carcinomas
Exposure to radiation to the head and neck area increases the risk of salivary gland can­cer. Some studies have also suggested that working with certain metals (nickel alloy dust) and minerals (silica dust) may increase the risk for salivary gland cancer. In men, smoking and heavy alcohol consumption was also associated with higher risk, but not in women. Hormonal dependence may also be important; early menarche and nulliparity are associ­ated with increased risk, whereas older age at full-term pregnancy and long duration of oral contraceptive use are associated with reduced risk.
Sarcomas of the Head and Neck
Sarcomas of t he head and neck constitute less than 1% of head and neck malig nancies. ey are divided into those arising from so tissue (STS) and those arising from bone (osteosarcoma).
Genetic Predisposition
Studies have shown that some groups of individuals are at an increased risk of developing STS. Among them are genetically predisposed individuals, such as those suering from neu­robromatosis (who are at risk of malignant peripheral neuroectodermal tumour [MPNT]), Li-Fraumeni syndrome and children with retinoblastoma (who are predisposed to osteosar­coma, rhabdomyosarcoma and brosarcoma). Other heritable syndromes associated with an increased risk of STS include Gardner syndrome and nevoid basal cell carcinoma syndrome.
Radiation, Viruses and Other Factors
Previous exposure to irradiation is another well-documented risk for both STS and osteo­genic sarcoma in other sites, but the head and neck is less commonly aected. Patients with chronic lymphoedema have an increased incidence of STS formation. Patients with Paget’s disease of bone, particularly the skull, are predisposed to osteogenic sarcoma. e role of viruses in the pathogenesis of STS has been investigated, but apart from the association of HIV with Kaposi’s sarcoma there is no conclusive proof available for a viral aetiology.
KEY POINTS
Squamous cell cancer is the most common head and neck malignancy, and it is related
mainly to alcohol and tobacco use.
HPV is now the leading cause of cancer of the oropharynx.
Other malignancies of the head and neck such as thyroid cancer, salivary gland cancer
and sarcomas are not related to alcohol or tobacco usage. The main causes of these cancers are less clear. Prior exposure to radiation in the head and neck area is one of the few identied risk factors.
Genetic predisposition to head and neck cancer is rare and is present in a few inherited
conditions such as Fanconi’s anaemia and Li-Fraumeni syndrome. MTC is a well-known example of a hereditary thyroid cancer secondary to a specic mutation in RET oncogene.
There is an important role of head and neck cancer prevention through alcohol and tobacco cessation, HPV vaccination and close follow-up of risk groups such as genetic conditions carriers.
260 Head and Neck
MOLECULAR BIOLOGY AND GENE THERAPY
52. MOLECULAR BIOLOGY AND GENE THERAPY
Molecular Genetics: DNA Structure and Function
Hereditary information in eukaryotes is stored in the form of double-stranded deoxyri­bonucleic acid (DNA) and is referred to as the genome. DNA forms a double helix struc­ture bonding complementary pairs of nucleotides, such as adenine (A) with thymine (T) and cytosine (C) with guanine (G). Within the coding part of DNA nucleotides on each strand are grouped in triplets, known as codons. Each codon sequence determines a sin­gle specic amino acid. Some codons are ‘stop’ codons, constituting a signal for arrest of translation. e overwhelming majority of DNA (99.9%) exists in the cell nucleus as the nuclear genome and the remaining DNA forms the mitochondrial genome, encoding 37 genes.
Each DNA molecule is packaged into a chromosome by complex folding of the DNA around proteins. Diploid human cells contain 22 pairs and a pair of sex chromosomes (XX or XY) that determines the sex of the organism. One of each pair of chromosomes is maternally inherited and the other is paternally inherited. e ends of the chromosomes are capped by telomeres, which are specialised structures that are involved in cell mortality. During nor­mal cell division, DNA replication is achieved by the separation of the two strands by DNA helicase. Each separated single strand then acts as a template for forming a new complemen­tary strand.
A gene is a region of the chromosomal DNA that produces a functional ribonucleic acid molecule (RNA). It comprises regulatory DNA sequences that determine when and in which cell types that gene is expressed; exons are coding sequences and interspersed introns are non-coding DNA sequences.
Transcription is the intra-nuclear process driven by the RNA polymerase whereby one DNA strand acts as a template for the synthesis of an RNA strand (uracil replaces thymine in RNA). is primary RNA transcript then undergoes post-transcriptional processing, or splicing. e mature mRNA migrates into the cytoplasm where it acts as a template for the synthesis of a polypeptide during translation, via ribosomes. Successive amino acids are added creating a polypeptide chain from to the triplet code on the mRNA, resulting in protein synthesis.
Other Regulators of Gene Expression
Small interfering RNAs (siRNAs; double stranded) and microRNAs (miRs; single stranded) are biologically signicant post-transcriptional regulators of gene expression. siRNAs and miRs are non-coding RNA molecules that base pair with mRNA via the RISC complex, pre­venting their translation into proteins. In addition, long non-coding RNAs (ncRNAs) have been identied that are thought to regulate various aspects of gene expression and they have been implicated in a number of diseases, including aging and cancer.
Molecular Aberrations of Cellular Biology
DNA mutation may occur as a result of base substitutions, as well as nucleotide insertions and deletions. Insertions and deletions of nucleotides are very rare in coding DNA. Base substitution is a more common form of mutation in coding DNA, which may have a range of consequences on the function of the gene: a loss of function; a gain in function, oen due to stabilisation of the active protein or no net functional eect. An example of a silent substitu­tion yielding no functional eect is seen when an amino acid may be encoded by dierent codons (e.g. GUA, GAC, GUG and GUU all encode valine), so a substitution of the third base results in no change to the amino acid. At the other extreme is the nonsense mutation, whereby a base substitution results in an early stop codon, which leads to truncation of the polypeptide and a dramatic reduction in function.
Head and Neck 261
MOLECULAR BIOLOGY AND GENE THERAPY
A proto-oncogene may be converted into an oncogene by a point mutation or by a simple increase in the copy number of the gene (gene amplication) resulting in an overproduc­tion of protein. Loss of function of a tumour suppressor gene is also oncogenic, which can occur a number of ways, including a missense mutation causing loss of protein func­tion, an early stop codon and transcriptional silencing. e methylation status of CpG islands surrounding the promoter regions of genes determines whether a particular gene is expressed within a cell, such that methylation of a CpG island ‘switches o’ the gene that it is regulating. Many tumour suppressor genes are now recognised to be inactivated by hypermethylation of the promoter region in malignant tumours. With inactivation of a tumour suppressor gene, it must be considered there are two alleles, with the theory that both alleles must be non-functioning and known as Knudson’s ‘two-hit’ hypothesis. is is well explained by hereditary tumours, where an inherited mutation eliminates the function of one allele, the so-called loss of heterozygosity (LOH), with a second somatic mutation (‘hit’) required to facilitate the oncogenic potential of the mutations. It is now known that tumour suppressors do not all t this model, and they can be haploinsucient (gene only functions in the presence of two wild-type alleles), dominant negative (where one mutated allele has an eect that dominates over the eect of the wild-type allele) or gain of function.
Gene Sequencing
Recently a variety of next-generation sequencing (NGS) methods have been applied to the eld. Methods involved include constructing a library of DNA fragments, which are ampli­ed using polymerase chain reaction (PCR). e sequence of the DNA is determined by synthesis, with dierent NGS platforms using dierent sequencing chemistry to determine which complementary bases have been added to the original DNA strands. Using massive parallel sequencing, this method is performed much more quickly and eciently than tradi­tional Sanger sequencing.
Proteomics and Metabolomics
Proteomics is the proling of proteins in cells and serum by two-dimensional gel analysis separating proteins by charge and mass, by X-ray crystallography and by mass spectrom­etry. Proteomics has the ability to identify post-translational modications, some of which are cancer cell specic, which would not be detected by genetic or expression proling. e power of this approach is particularly evident in cancer studies as it has the ability to com­pare the entire protein pattern of tumour tissue and normal tissue in a manner analogous to comparative genomic hybridisation.
Metabolomics is the global analysis of metabolites but is a relatively new discipline and no single technique is suitable for the analysis of all dierent types of molecule. erefore, a mixture of techniques such as gas chromatography, high-pressure liquid chromatography and capillary electrophoresis are used to separate metabolites and the molecules are then identied using methods such as mass spectrometry. Metabolomics has already been applied to the detection of oral cancer in saliva and serum.
Gene Therapy
Gene therapy oers a novel paradigm that leads to the destruction of tumour cells in cancer patients. To date, the approaches to target specic cancer cells fall into four basic categories: (1) chemosensitisation, (2) cytokine gene transfer, (3) inactivation of protooncogene produc­tion and (4) selective oncolytic viruses.
Selective sensitisation of cancer cells using gene therapy would be an ideal way to kill cancer cells. Using this approach, the expected gene is delivered only to cancer cells and then a second therapy (e.g. radiotherapy or chemotherapy) is used to induce killing in the
262 Head and Neck
MOLECULAR BIOLOGY AND GENE THERAPY
cells that express the transgene. Eciency and targeting have been shown to be dicult in vivo largely due to the bystander eect, where an infected cell spreads the expressed genes to the cells surrounding it via cell–cell contacts, reducing the method eciency in the targeted cells.
e host immune response has been shown to play a role in cancer eradication. In addi­tion to generalised suppression increasing the risk of carcinogenesis, it has been shown that individuals with head and neck cancer lack an eective local immune response even early in the disease. is dysfunction occurs as a result of the normal immune system not recognising the tumour cells. Causes of this include immunological ignorance, down­regulation of major histocompatibility complexes and loss of costimulatory receptor and pathways. In some tumours, the cytokine stimulatory pathways (interleukin [IL]-2, inter­feron-gamma and IL-12) that normally upregulate the normal tumour immune response are suppressed. One method to break this immune dysregulation is to overexpress the downregulated cytokines.
Restoring the function of a key cellular gene whose dysfunction has resulted in cancer pro­gression is a major goal of gene therapy. e most common mutations of key genes in squa­mous cell cancer of the head and neck are p53 and p16. p53 plays a role in triggering cell death in many dierent pathways involving apoptosis. Gendicine®, a drug with modied adenovi­rus harbouring p53 gene, was approved in China in 2004, becoming the rst gene therapy approved for clinical use in humans. However, the western version of Ad-p53 (Advexin®) for the treatment of head and neck cancer was refused approval by the U. S. Food and Drug Administration in 2008.
e future of restoring function via correction of genetic defects found in cancer may lie with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated nuclease 9 (Cas9) gene editing. CRISPR-Cas9 utilises the DNA cutting action of the Cas9 protein to create double-stranded DNA breaks, has relative high eciency and accuracy for disruption gene transcription and can be adapted for editing gene transcription. Safety trials for the delivery of CRISPR-edited T cells into patients have started.
With increased knowledge of the genetic defects in cancer, delivery vectors aimed selectively at tumour cells provide another research challenge. e translation of molecular biology research into clinical practice, ‘from laboratory to bedside,’ is without a doubt the greatest challenge facing the clinician scientist. Progress so far has been largely at the level of disease classication, premorbid diagnosis and patient counselling. However, several discrete arms to translational research have hinted at the future role of genetic analysis determining the likely eectiveness of existing anti-cancer treatments.
KEY POINTS AND FUTURE RESEARCH
Genetic sequencing data potentially provides more accurate diagnosis and prognosis
than conventional histopathological techniques.
There is the potential for therapeutic restoration of DNA or protein function, as well as
exploitation of a genetic abnormality for targeting therapy.
Although genomics and other omics has generated a large body of data, cancers
are complicated tissues. Future research may shift toward understanding the cancer environment and how perhaps to target this in future therapeutic strategies.
Our increased understanding of cellular oncogenesis will lead to the development of
novel cancer therapies in the years to come.
Gene therapy is likely to be a part of these therapies.
A head and neck oncologist will need to understand both the viral vectors and their strategies of implementation to offer a full range of treatment to the cancer patient.
Head and Neck 263
IMAGING OF THE NECK
53. IMAGING OF THE NECK
Introduction
Current imaging options for the head and neck include:
Plain X-rays: ey are limited to detecting ingested radiopaque foreign bodies, assess-
ing the dentition in oncological patients and those presenting with oor of mouth abscesses. Ultrasound (US): It is quick, non-invasive, readily available, inexpensive and does not
use ionising radiation. It is heavily operator dependent. Widely used for evaluating neck lumps, lymph nodes, thyroid and salivary glands, and guiding ne-needle aspi­ration (FNA) or core biopsies. Computed tomography (CT): is is used extensively in staging cancer patients and
detecting neck masses or abscesses. e entire neck can be scanned in a few seconds, and images reconstructed in any plane. Intravenous iodinated contrast agent neces­sary due to its low so-tissue resolution. Radiation dose and dental artifact are an important consideration. Magnetic resonance imaging (MRI): is produces images with excellent so-tissue
contrast. It does not use ionising radiation. Contraindicated in certain patients with metallic foreign bodies, prosthesis and implanted devices. Long acquisition times result in motion artifact. Positron emission tomography (PET): is is a functional imaging technique where
hyperme tabolic cel ls accumul ate tracer, usual ly uorine-18-labellfe d 2-uoro-2-deoxy­-glucose (FDG). e combination of CT and PET allows accurate anatomical localisation, which is especially useful in assessing patients with an unknown primar y, and in post-treatment patients. Contrast swallow: is is useful for assessing the presence of leaks following lar yngeal/
pharyngeal surgery. Videouoroscopy is important in assessing head and neck cancer patients with dysphagia before or aer treatment. Sialography: is provides excellent luminal depiction of glandular anatomy; how-
ever, it is invasive and can cause trauma or be unsuccessful. Scintigraphy: is provides good quantication of gland function but poor anatomical
correlation and radiation burden.
Head and Neck Cancer
Cross-sectional imaging helps to assess the size, location and deep extension of tumour, involvement of surrounding structures, presence of distant metastases and allows post-ther­apy surveillance and assessment of treatment.
Nasopharyngeal Cancer (NPC)
Locally aggressive, early metastases despite early primary.
CT allows assessment of the primary tumour and metastases (Figure 53.1).
MRI better at demonstrating so-tissue extent, intracranial extension and skull base
bone marrow changes (Figure 53.2). PET-CT for staging, assessment of recurrence and evaluating the nasopharynx in
patients presenting with unknown primary.
Oral Cavity Tumours
Challenging radiologically due to surrounding anatomy.
Small tumours oen not visualised by imaging.
264 Head and Neck
IMAGING OF THE NECK
Figure 53.1 Axial CT showing nasopharyngeal carcinoma (white arrow) and retained secretions
left mastoid air cells (black arrow) due to Eustachian tube obstruction.
Figure 53.2 MRI showing left nasopharyngeal cancer extending into the pterygopalatine fossa
(black arrow) and vidian canal (white arrow) (a) and into the foramen rotundum (black arrow) (b).
CT shows better evaluation of cortical bone (Figure 53.3), but dental amalgam is a
frequent diagnostic issue. MRI is better at characterising local tumour extent, perineural spread and bone mar-
row involvement.
Oropharyngeal Tumours
Oropharyngeal tumours include tonsil, base of tongue, so palate and posterior pha-
ryngeal wall cancers. Oen present with a nodal mass and no obvious primary tumour.
CT/MRI both useful imaging modalities.
PET has a higher sensitivity for detection of primary tumour and cervical metastases.
PET-CT is slightly complicated by the normal physiological uptake in the oropharynx
(Figure 53.4). Post-treatment PET-CT to assess therapy response.
Head and Neck 265
IMAGING OF THE NECK
Figure 53.3 Axial CT showing destruction of the inner cortex of the right mandible (arrow) in a
histologically proven intraosseous squamous cell carcinoma.
Figure 53.4 PET-CT showing increased activity in the right tongue base (white arrow) in a patient
presenting with a right-sided neck mass (black arrow) and no apparent primary on clinical exami­nation or conventional CT. Note the normal physiological activity in the left tongue base.
Hypopharyngeal Tumours
Hypopharynx consists of the pyriform sinus/fossa, post-cricoid region and posterior
hypopharyngeal wall. Imaging importantly evaluates the larynx, thyroid cartilage, and nodal status, and
usually results in tumour upstaging. CT generally preferred modality (Figure 53.5).
PET-CT for detection of residual/recurrent tumour following treatment.
Laryngeal Tumours
Most common head and neck malignancy; the majority are squamous cell carcinoma
(SCC). Imaging allows evaluation of submucosal disease, laryngeal cartilage and extra-
laryngeal structure involvement, state of the airway and nodal status.
266 Head and Neck
IMAGING OF THE NECK
Figure 53.5 Axial contrast CT showing a large hypopharyngeal posterior wall tumour extending
into the prevertebral muscles.
Figure 53.6 Axial contrast CT showing a large left transglottic tumour (long black arrow) with com-
pletely destroyed left arytenoid (white arrow) and sclerotic left cricoid cartilage (short black arrow).
CT is the preferred modality (Figure 53.6).
US can be used to identify extra-laryngeal spread (Figure 53.7).
PET-CT, CT or MRI is used for detection of residual/recurrent tumour following
treatment.
Neck Lumps
e imaging of patients presenting with a neck lump depends on the age of the patient, clinical history and location of the mass.
Thyroglossal Duct Cyst
Intimately related to the hyoid bone, most below (65%) or at level of hyoid bone (15%).
75% occur in the midline, remainder up to 2 cm o the midline.
Imaging helps identify relationship to hyoid, presence or absence of normal thyroid
tissue, and any solid material within the cyst (Figure 53.8).
Head and Neck 267